All finalists get to pitch their inventions to venture capitalists and "angel investors" who will be in attendance to get their hands on the next big thing. "The IShow is known for picking the cream of the crop. We know we're facing stiff competition. But, we're passionate about our design, our team and our company moving forward", stated Steve Xu. "I can tell you this: We're going to Palm Desert to win."
Though the team's device looks a lot like a standard bathroom scale connected to a bicycle-like handlebar, it is actually a heavy-duty piece of technology meant to offer congestive heart failure patients both peace of mind and significant health care costs savings.
"Nithan and Steve are developing a technology that is very useful medically, will benefit a large group of patients, and is simple for people to use", stated Dr. Cliff Dacso, director of the Abramson Center, the John S. Dunn Sr. Research Chair in General Internal Medicine at The Methodist Hospital, and professor at University of Houston (UH)'s College of Technology. "Such elegance and purpose of design are rare and tend to be highly sought by investors."
The device, known as the BlueScale, simultaneously records a variety of patient information, including weight, heart rate, blood pressure and cardiac output, in a mere 10 seconds. When combined, those daily measurements offer a good picture of the health of the patient's cardiovascular system and can be predictive of acute episodes, such as heart failure.
If used daily, the device will indicate when a patient needs to seek medical attention, potentially heading off dangerous episodes and preventing costly emergency room visits and ambulance rides, the inventors said.
Luca Pollonini, a post-doctoral fellow at UH who worked with the team, called the device "intuitive". "The design of Blue Scale is inspired by two everyday actions: stepping on a bathroom scale and riding a bicycle. Since everyone is familiar with these simple actions, the usage of Blue Scale is seamless", Luca Pollonini stated.
Nithin Rajan, who, like Steve Xu, is a research associate at The Methodist Hospital Research Institute, said the device has received good reviews from patients involved in preliminary clinical testing, which will make convincing investors that much easier. "I am excited about the marketing presentation, even with limited experience with investors, because I look forward to telling our story, which I firmly believe is compelling and important to changing the way we deliver health care in this country", he stated.
Steve Xu and Nithin Rajan both said they were emboldened when their product landed them at the IShow. "When we were accepted, it was truly an exciting moment, because, while we believe in the technology to our core, sometimes we need to hear it from someone else who has no vested interest", Nithin Rajan stated.
The device was developed at the Abramson Center for the Future of Health, a joint partnership between UH's College of Technology and The Methodist Hospital Research Institute. "A central mission of the Abramson Center is to improve chronic disease management", Nithin Rajan stated. "We are developing technologies for diabetes and asthma management as well, but the BlueScale is the most advanced technology. During the course of the initial clinical trial, I spoke to many patients with heart failure, and it has made this project a very personal one rather than just a research exercise."
Marco J. Mariotto, UH's dean of graduate and professional studies and co-director of the Abramson Center, lauded the student-driven effort to deliver a low-cost, technology-driven health aid "for addressing the management of chronic disease, especially for underserved populations". "It represents the intersection of engineering technology, health care and business and fits with UH's role in producing entrepreneurs, especially in the melding of UH's expertise in science, engineering and business with our Methodist partner's expertise in medicine", Marco J. Mariotto stated.
The University of Houston, Texas' premier metropolitan research and teaching institution, is home to more than 40 research centres and institutes and sponsors more than 300 partnerships with corporate, civic and governmental entities. UH, the most diverse research university in the country, stands at the forefront of education, research and service with more than 36.000 students.
The Methodist Hospital Research Institute conducts groundbreaking translational and clinical research to provide the best possible care for its patients. Its goal is to make the latest laboratory findings available to patients in the form of new treatments and clinical trials as rapidly as possible.